Alpine Immune Sciences Inc (ALPN)
64.62
+0.04
(+0.06%)
USD |
NASDAQ |
May 01, 15:55
Alpine Immune Sciences Price: 64.62 for May 1, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 30, 2024 | 64.63 | 64.72 | 64.56 | 64.58 | 1.412M |
Apr 29, 2024 | 64.61 | 64.70 | 64.57 | 64.70 | 1.631M |
Apr 26, 2024 | 64.58 | 64.63 | 64.51 | 64.56 | 1.329M |
Apr 25, 2024 | 64.57 | 64.65 | 64.54 | 64.62 | 1.769M |
Apr 24, 2024 | 64.57 | 64.63 | 64.56 | 64.57 | 1.180M |
Apr 23, 2024 | 64.58 | 64.70 | 64.50 | 64.55 | 3.104M |
Apr 22, 2024 | 64.52 | 64.58 | 64.44 | 64.58 | 1.794M |
Apr 19, 2024 | 64.43 | 64.55 | 64.40 | 64.55 | 3.979M |
Apr 18, 2024 | 64.42 | 64.48 | 64.42 | 64.43 | 2.486M |
Apr 17, 2024 | 64.42 | 64.50 | 64.42 | 64.46 | 2.633M |
Apr 16, 2024 | 64.40 | 64.50 | 64.40 | 64.50 | 2.973M |
Apr 15, 2024 | 64.39 | 64.50 | 64.37 | 64.42 | 3.550M |
Apr 12, 2024 | 64.36 | 64.57 | 64.34 | 64.37 | 4.100M |
Apr 11, 2024 | 64.18 | 64.45 | 64.15 | 64.40 | 34.59M |
Apr 10, 2024 | 37.89 | 47.84 | 37.43 | 47.04 | 12.23M |
Apr 09, 2024 | 39.16 | 39.63 | 37.57 | 38.94 | 1.175M |
Apr 08, 2024 | 34.83 | 39.50 | 34.25 | 38.53 | 2.587M |
Apr 05, 2024 | 35.14 | 36.13 | 34.51 | 34.91 | 1.100M |
Apr 04, 2024 | 38.35 | 38.42 | 34.31 | 35.33 | 1.579M |
Apr 03, 2024 | 39.00 | 40.14 | 36.66 | 38.11 | 1.647M |
Apr 02, 2024 | 39.72 | 41.16 | 39.01 | 39.21 | 1.005M |
Apr 01, 2024 | 39.31 | 40.32 | 37.93 | 40.22 | 1.355M |
Mar 28, 2024 | 38.65 | 41.04 | 37.18 | 39.64 | 1.462M |
Mar 27, 2024 | 37.70 | 39.04 | 36.68 | 38.65 | 787120.0 |
Mar 26, 2024 | 37.86 | 39.15 | 37.42 | 37.45 | 776940.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.151
Minimum
Mar 17 2020
64.70
Maximum
Apr 29 2024
10.30
Average
8.675
Median
Price Benchmarks
Vertex Pharmaceuticals Inc | 401.94 |
Eliem Therapeutics Inc | 7.53 |
Regeneron Pharmaceuticals Inc | 904.13 |
Vera Therapeutics Inc | 42.35 |
Eyenovia Inc | 0.90 |
Price Related Metrics
PS Ratio | 54.87 |
Price to Book Value | 12.92 |
Earnings Yield | -0.99% |
Market Cap | 4.237B |